Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial.
Efficacy and safety of the oral administration of short-acting exenatide for glucose control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial